| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |